N-芴甲氧羰基-(N’-叔丁氧羰基)-D-鸟氨酸 | 118476-89-4

• 物质功能分类: 生物化工 - 生化试剂 - 氨基酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 芴
• 中文名称: N-芴甲氧羰基-(N’-叔丁氧羰基)-D-鸟氨酸
• 中文别名: N-芴甲氧羰基-(N'-叔丁氧羰基)-D-鸟氨酸
• 英文名称: (R)-N5-(tert.-butoxy-carbonyl)-N2-(9-fluorenylmethoxycarbonyl)-ornithine
• 英文别名: Fmoc-D-Orn(Boc)-OH；(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
• CAS: 118476-89-4
• 化学式: C₂₅H₃₀N₂O₆
• mdl: MFCD00077065
• 分子量: 454.523
• InChiKey: JOOIZTMAHNLNHE-OAQYLSRUSA-N

物化性质

• 沸点：
  679.0±55.0 °C(Predicted)
• 密度：
  1.226±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  33
• 可旋转键数：
  11
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  114
• 氢给体数：
  3
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  N
• 安全说明：
  S60,S61
• 危险类别码：
  R50/53
• WGK Germany：
  3
• 海关编码：
  2924 29 70
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  密封，在温室中保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Fmoc-D-Orn(Boc)-OH
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Fmoc-D-Orn(Boc)-OH
CAS number: 118476-89-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C25H30N2O6
Molecular weight: 454.5

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

Fmoc-D-Orn(Boc)-OH 是一种用于合成双喹啉类似物的试剂，它不仅具备抗利什曼活性，还表现出对抗一系列致病菌和真菌的抗菌作用。

反应信息

• 作为反应物：
  描述：

  N-芴甲氧羰基-(N’-叔丁氧羰基)-D-鸟氨酸 生成 (5S,8S,15R)-15-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(2S)-1-[[(2S)-1-[[(2S,3R)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-5-benzyl-3,6,10,16-tetraoxo-1,4,7,11-tetrazacyclohexadecane-8-carboxamide
  参考文献：
  名称：

  SCHILLER, PETER W.;NGUYEN, THI M. -D.;LEMIEUX, CAROLE, TETRAHEDRON, 44,(1988) N 3

  摘要：

  DOI：

文献信息

• Synthesis, stability and mechanistic studies of potent anticryptococcal hexapeptides
  作者：Kitika Shenmar、Krishna K. Sharma、Nishima Wangoo、Indresh K. Maurya、Vinod Kumar、Shabana I. Khan、Melissa R. Jacob、Kulbhushan Tikoo、Rahul Jain

  DOI：10.1016/j.ejmech.2017.03.046

  日期：2017.5

  which has been exploited in the present study by synthesizing a series of hexapeptides that exhibits promising activity against a panel of Gram-negative and Gram-positive bacteria and various pathogenic fungal strains; the most exemplary activity was observed against Cryptococcus neoformans. The peptides 3, 24, 32 and 36 displayed potent anticryptococcal activity (IC50 = 0.4-0.46 μg/mL, MIC = 0.63-1.25

  免疫功能低下患者中隐球菌病的发病率不断增长，因此需要一种能够根除该病的新型药物疗法。与传统治疗剂相比，基于肽的药物治疗具有许多优势，传统治疗剂已在本研究中得到利用，其方法是合成一系列六肽，这些六肽对一组革兰氏阴性和革兰氏阳性细菌以及各种病原性真菌菌株显示出有希望的活性; 观察到了对新型隐球菌的最典型的活性。肽3、24、32和36表现出强大的抗隐球菌活性（IC50 = 0.4-0.46μg/ mL，MIC = 0.63-1.25μg/ mL，MFC = 0.63-1.25μg/ mL），并且在蛋白水解条件下具有稳定性。除此之外，其他几种肽还显示出对病原菌的抑制作用。突出的肽包括表现出IC50值在2.1和3.6μg/ mL之间的肽18-20和26，针对金黄色葡萄球菌和耐甲氧西林的S的MIC为5-20μg/ mL和MBC为10-20μg/ mL。金黄色的。通过扫描电子显微镜和透射电子显微镜研究证
• Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines)
  作者：Kirandeep Kaur、Meenakshi Jain、Shabana I. Khan、Melissa R. Jacob、Babu L. Tekwani、Savita Singh、Prati Pal Singh、Rahul Jain

  DOI：10.1016/j.bmc.2010.11.036

  日期：2011.1

  In continuing our search of potent antimalarials based on 8-aminoquinoline structural framework, three series of novel bis(8-aminoquinolines) using convenient one to four steps synthetic procedures were synthesized. The bisquinolines were evaluated for in vitro antimalarial (Plasmodium falciparum), antileishmanial (Leishmania donovani), antimicrobial (a panel of pathogenic bacteria and fungi), cytotoxicity

  在继续研究基于 8-氨基喹啉结构框架的有效抗疟药的过程中，使用方便的一到四步合成程序合成了三个系列的新型双（8-氨基喹啉）。对双喹啉类药物的体外抗疟（恶性 疟原虫）、抗利什曼 原虫（多诺瓦尼利什曼原虫）、抗微生物剂（一组致病细菌和真菌）、细胞毒性、β-血红素抑制和高铁血红蛋白 (MetHb) 形成活性进行了评估。与母体药物伯氨喹相比，几种化合物表现出优异的抗疟活性。选择的化合物（44，61和79时在体内血液裂殖抗疟疾活性测试）（Plasmodium berghei ) 显示出有效的血液裂殖体活动。双喹啉的 MetHb 形成可以忽略不计（0.2-1.2%），这突显了它们在治疗葡萄糖-6-磷酸脱氢酶缺乏症患者中的潜力。所述双喹啉类似物（36，73和79）也表现出体外活性antileishmanial看好，和抗菌活性（43，44和76对致病细菌和真菌的面板）。这项研究的结果提供了证据，证明双（8
• γ-(S)-Trifluoromethyl proline: evaluation as a structural substitute of proline for solid state ¹⁹F-NMR peptide studies
  作者：Vladimir Kubyshkin、Sergii Afonin、Sezgin Kara、Nediljko Budisa、Pavel K. Mykhailiuk、Anne S. Ulrich

  DOI：10.1039/c5ob00034c

  日期：——

  values for intact proline. Therefore, the gamma-trifluoromethyl proline was suggested as a structurally low-disturbing proline substitution in peptides for their structural studies by (19)F-NMR. Indeed, the exchange of native proline for gamma-trifluoromethyl proline in the peptide antibiotic gramicidin S was shown to preserve the overall amphipathic peptide structure. The utility of the amino acid as

  γ-（4S）-三氟甲基脯氨酸是根据改良的文献方法合成的，具有改进的产率（以克为单位）。使用N-乙酰基甲基酯模型表征了由氨基酸形成的酰胺键的构象性质。发现异构化的酰胺族（s-反式对s-顺式）和热力学参数与完整脯氨酸的相应值相似。因此，对于通过（19）F-NMR进行结构研究，γ-三氟甲基脯氨酸被认为是肽中结构上低干扰的脯氨酸取代。确实，在肽抗生素短杆菌肽S中天然脯氨酸换成γ-三氟甲基脯氨酸被证明保留了整个两亲性肽结构。
• Studies on the synthesis of peptides containing dehydrovaline and dehydroisoleucine based on copper-mediated enamide formation
  作者：Franziska Gille、Andreas Kirschning

  DOI：10.3762/bjoc.12.55

  日期：——

  antibiotic myxovalargin is reported. Peptide formation is based on a copper-mediated C-N cross-coupling protocol between an acyl amide and a peptidic vinyl iodide. The presence of a neighboring arginine in the vinyl iodide posed a challenge with respect to the choice of the protecting group and the reaction conditions. It was found that ornithine - a suitable precursor - is better suited than arginine for

  据报道制备了在抗生素粘多糖中存在的含有脱氢缬氨酸和脱氢异亮氨酸部分的肽片段。肽的形成基于酰基酰胺和肽基碘乙烯之间的铜介导的CN交叉偶联方案。在保护基的选择和反应条件方面，乙烯基碘中相邻精氨酸的存在提出了挑战。已发现鸟氨酸（一种合适的前体）比精氨酸更适合于实现CN交叉偶联反应的良好收率。优化的条件用于以正确的立体化学合成含有相邻鸟氨酸的肽32、33、39和40以及含有脱氢异亮氨酸的三肽44。
• Synthesis and evaluation of strand and turn modified ring-extended gramicidin S derivatives
  作者：Annemiek D. Knijnenburg、Varsha V. Kapoerchan、Gijsbert M. Grotenbreg、Emile Spalburg、Albert J. de Neeling、Roos H. Mars-Groenendijk、Daan Noort、José M. Otero、Antonio L. Llamas-Saiz、Mark J. van Raaij、Bep Ravensbergen、Peter H. Nibbering、Gijs A. van der Marel、Herman S. Overkleeft、Mark Overhand

  DOI：10.1016/j.bmc.2011.04.031

  日期：2011.6

  describe the crystal structure of previously reported ring-extended gramicidin S (GS) derivative 2 (GS14K4), containing a d-amino acid residue in one of the β-strand regions. This structure is in agreement with a previously reported modeling study of the same molecule. The polar side chain of the additional d-amino acid residue is positioned at the same face of the molecule as the hydrophobic side chains,

  在本文中，我们描述了先前报道的扩环的短杆菌肽S（GS）衍生物2（GS14K4）的晶体结构，该衍生物在β链区域之一中包含d-氨基酸残基。该结构与先前报道的相同分子的建模研究一致。额外的d-氨基酸残基的极性侧链与疏水侧链位于分子的同一侧，我们认为由于该化合物2的疏水性比其中链区位于其中的延伸GS衍生物的疏水性小得多完全由l组成-氨基酸。使用该骨架结构作为我们的基准，我们制备了一系列小环延伸的GS类似物，这些类似物在转角区域具有疏水性各不相同的糖氨基酸二肽等排体。我们表明，通过这种方法，可以调节扩展的GS类似物的疏水性，而不会影响二级结构（从NMR和CD光谱中观察到）。生物学评估表明，疏水性与细胞毒性有关，但仍然由于亲水性过强而无法有效裂解人红细胞的GS类似物而导致细菌溶解。